Arcellx(ACLX)
REDWOOD CITY, CA
Biotechnology1 H-1B visas (FY2023)Focus: Adaptive Immune Cell Therapies
Arcellx is a life sciences company focused on Adaptive Immune Cell Therapies.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
SPRX002
Acute Myeloid LeukemiaClinical Trials (1)
NCT05457010Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Phase 1anitocabtagene-autoleucel
Relapsed and Refractory Multiple Myelomaanito-cel
Muscular DiseasesClinical Trials (1)
NCT06626919A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Phase 1anitocabtagene-autoleucel
Multiple MyelomaAnitocabtagene Autoleucel
Multiple MyelomaOpen Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 2 clinical trials
H-1B (2023): 1 approval
SEC Filings: 2 available
Financials (FY2025)
Revenue
$110M0%
R&D Spend
$134M(121%)11%
Net Income
-$71MCash
$106MHiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub